Accolade, Inc. (ACCD)
| Market Cap | 915.55M |
| Revenue (ttm) | 380.06M |
| Net Income (ttm) | -141.54M |
| Shares Out | 76.23M |
| EPS (ttm) | -1.89 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 903,184 |
| Open | 12.84 |
| Previous Close | 12.85 |
| Day's Range | 11.97 - 12.92 |
| 52-Week Range | 6.33 - 17.01 |
| Beta | 2.06 |
| Analysts | Strong Buy |
| Price Target | 15.39 (+28.14%) |
| Earnings Date | Jan 8, 2024 |
About ACCD
Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialis... [Read more]
Financial Performance
In 2022, Accolade's revenue was $363.14 million, an increase of 17.13% compared to the previous year's $310.02 million. Losses were -$459.65 million, 273.3% more than in 2021.
Financial StatementsAnalyst Forecast
According to 14 analysts, the average rating for ACCD stock is "Strong Buy." The 12-month stock price forecast is $15.39, which is an increase of 28.14% from the latest price.
News
License Global Releases 2023 Annual Accolade, The Influentials
SANTA MONICA, CA / ACCESSWIRE / December 7, 2023 / License Global, the premier publication and leading source of news and trends for the global consumer product and licensing industries, has released ...
Accolade To Present at Piper Sandler 35th Annual Healthcare Conference
SEATTLE, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the Piper Sandler 35th An...
Accolade Announces Repurchase of $76.5 Million of 0.50% Convertible Senior Notes Due 2026
SEATTLE, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it has entered into separate, privately negotiated transactions with certain holders of its outstanding 0....
Accolade To Present at Stephens Annual Investment Conference
SEATTLE, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the Stephen Annual Invest...
Accolade Named to 2023 Deloitte Technology Fast 500™
Attributes 227% revenue growth to a relentless focus on delivering exceptional outcomes SEATTLE , Nov. 8, 2023 /PRNewswire/ -- Accolade today announced it has been named to the Deloitte Technology Fas...
GLP-1 Coverage in Employer Plans Could Nearly Double in 2024
Employer survey: 25% of employers currently offer coverage and most experience positive outcomes; 4 in 10 consider it an immediate concern and intend to offer in 2024; while 21% of HR decision-makers ...
Accolade Announces Results for Fiscal Second Quarter 2024
SEATTLE, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2023.
Accolade to Announce Fiscal Second Quarter 2024 Financial Results
SEATTLE, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal second quarter 2024 financ...
Accolade Expands Physician-Executive Leadership to Enhance Care Delivery and Improve the Healthcare Experience
Welcomes Dr. Connie Hwang as chief medical officer, creates roles of chief health officer and chief nursing officer SEATTLE , Sept. 18, 2023 /PRNewswire/ -- Accolade (Nasdaq: ACCD) announced the expan...
CORRECTING and REPLACING -- Accolade To Present at Upcoming Investor Conferences
SEATTLE, Sept. 06, 2023 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Sept. 5, 2023 by Accolade, Inc. (NASDAQ: ACCD), please note that in the second bullet, the time of the Morgan...
Named as a Top Edge Computing Company to Watch in 2023: FusionLayer Receives an Accolade for Its Hybrid Edge Networking Vision
HELSINKI--(BUSINESS WIRE)-- #MEC--FusionLayer Inc. has been featured as one of the top Edge Computing companies to watch in 2023 in the latest edition of Insights Success magazine. With an impressive ...
Chargeback Gurus Nabs Industry Accolade by The Digital Banker
PLANO, Texas--(BUSINESS WIRE)--Chargeback Gurus (CBG), an industry leader in chargeback prevention and revenue recovery solutions, today announced it has been named the Best Payments Solution by a Ven...
Masan reinforces its brand through significant domestic and international accolade
Through ongoing winning awards, Masan strengthens its esteemed brand Masan reinforces its brand through significant domestic and international accolades. Masan's strong dedication to shareholders and ...
Accolade: A Rising Personalized AI-Powered Healthcare Platform
Accolade Inc. NASDAQ: ACCD is an artificial intelligence (AI) powered healthcare platform that provides personalized healthcare guidance for employers and workers. The platform helps people manage the...
Accolade Announces Results for Fiscal First Quarter 2024
SEATTLE, June 29, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2023.
Accolade to Announce Fiscal First Quarter 2024 Financial Results
SEATTLE, June 13, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal first quarter 2024 financia...
Equip Partnership Adds Eating Disorder Support to Accolade's Trusted Partner Ecosystem
Accolade and Equip offer employers purpose-built integrations to address barriers to eating disorder treatment. SEATTLE , June 7, 2023 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD), the company that p...
Report: Employees are Overwhelmed, Delaying Care at High Rates
New health trends report explores causes of stress and offers solutions, including virtual care expansion and enhanced health equity. SEATTLE , June 5, 2023 /PRNewswire/ -- Accolade (Nasdaq: ACCD), th...
Accolade To Present at Stifel 2023 Cross Sector Insight Conference
SEATTLE, June 01, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the Stifel 2023 Cross Sec...
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May - Bio-Rad Laboratories (NYSE:BIO), Accolade (NASDAQ:ACCD)
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2023
SEATTLE, April 27, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal fourth quarter and full year ended February 28, 2023.
Accolade to Webcast Analyst Day on May 8, 2023
SEATTLE, April 24, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will host an Analyst Day at the Wynn Las Vegas...
Accolade to Announce Fiscal Fourth Quarter 2023 Financial Results
SEATTLE, April 11, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal fourth quarter 2023 financ...
Healthcare company Accolade lays off workers and closes offices
Seattle and Philadelphia area-based primary healthcare company Accolade is cutting its workforce and closing or reducing some facilities, according to a recent regulatory filing.
Accolade Welcomes Lyra Health to Its Trusted Partner Ecosystem
Accolade and Lyra will offer employers purpose-built integrations that help address barriers to behavioral health care SEATTLE , March 6, 2023 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD), the compan...